USPTO Grants Patent for Compounds Inhibiting Protozoan Parasites

The United States Patent and Trademark Office (USPTO) has issued patent US12582694B2 to the University of South Florida. The patent details compounds, formulations, and methods aimed at inhibiting the invasion and subsequent liver-stage development of protozoan parasites, with a specific focus on Plasmodium falciparum, the parasite responsible for malaria.

This grant represents a new intellectual property asset in the therapeutic area of parasitic disease treatment. While not a regulatory rule or enforcement action, it signifies a step forward in potential drug development. Companies in the pharmaceutical and biotechnology sectors involved in anti-parasitic drug research may find this patent relevant for competitive analysis or potential licensing opportunities.